Mavacamten
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 515 publications
Mavacamten Versus Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: An Echocardiography-Derived Pressure-Volume Analysis.
Journal: Circulation. Heart failure
Published: April 13, 2026
RoMa: A Cardiopulmonary Exercise Testing Based Risk Tool in Hypertrophic Cardiomyopathy.
Journal: Journal of the American Heart Association
Published: April 09, 2026
Antihypertensive Dosing During Mavacamten Therapy for Obstructive Hypertrophic Cardiomyopathy.
Journal: Journal of Cardiac Failure. Intersections
Published: April 08, 2026
Emerging treatments in hypertrophic cardiomyopathy: a focus on cardiac myosin inhibitors.
Journal: Expert opinion on pharmacotherapy
Published: April 06, 2026
Mavacamten in Adolescents with Obstructive Hypertrophic Cardiomyopathy.
Journal: The New England journal of medicine
Published: March 30, 2026
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy.
Journal: The New England journal of medicine
Published: March 26, 2026
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy. Reply.
Journal: The New England journal of medicine
Published: March 26, 2026
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy.
Journal: The New England journal of medicine
Published: March 26, 2026
Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy.
Journal: The New England journal of medicine
Published: March 26, 2026
Assessing Aortic Stenosis Severity in Dynamic Left Ventricular Outflow Obstruction Using Echo Doppler.
Journal: CASE (Philadelphia, Pa.)
Published: March 25, 2026
Targeting Myocardial Energetics in Nonobstructive Hypertrophic Cardiomyopathy (nHCM): The Role of Ninerafaxstat.
Journal: Journal of cardiovascular pharmacology
Published: March 17, 2026
Last Updated: 04/28/2026